Skip to content

Abnormal Circulating Beta Globulin Concentration C4476797

Published: July 22, 2026Updated: August 20, 2026

Beta globulins are blood proteins involved in transport and immune function. Abnormal levels may suggest liver disease, kidney problems, or immune disorders. Treatment depends on identifying the specific cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Unexplained Bleeding

Serious bleeding from gums, nose, or internal organs indicating severe coagulation dysfunction requiring immediate evaluation.

Seek immediate medical attention if experiencing uncontrolled bleeding, bloody vomit, or blood in stool.

Fatigue and Weakness

(constitutional)

Persistent feeling of tiredness and lack of energy that does not improve with rest, often due to altered protein levels affecting oxygen transport in blood.

Frequency: 70-85% of patients

Easy Bruising or Bleeding

(hematologic)

Unexplained bruises appearing on skin and prolonged bleeding from minor cuts due to impaired blood clotting function related to protein abnormalities.

Frequency: 60-75% of patients

Peripheral Edema

(cardiovascular)

Swelling in legs, ankles, and feet due to decreased oncotic pressure from abnormal protein levels affecting fluid balance in blood vessels.

Frequency: 40-55% of patients

Unexplained Weight Loss

(constitutional)

Gradual, unintentional loss of body weight without dietary changes, often accompanying chronic illness and metabolic disturbances.

Frequency: 35-50% of patients

Frequent Infections

(immunologic)

Recurring bacterial or viral infections due to compromised immune function from altered beta-globulin proteins that normally support antibody activity.

Frequency: 30-45% of patients

Skin Rash or Pruritus

(dermatologic)

Itchy skin or patchy rash that may appear due to immune complex deposition or nutritional deficiencies associated with protein abnormalities.

Frequency: 15-25% of patients

Loss of Appetite

(gastrointestinal)

Reduced desire to eat, often accompanied by early fullness, related to metabolic changes and organ involvement in protein metabolism disorders.

Frequency: 20-30% of patients

Bone Pain

(musculoskeletal)

Deep, persistent bone pain especially in back, hips, or ribs potentially indicating plasma cell disorder affecting bone marrow.

Frequency: 5-15% of patients

Peripheral Neuropathy

(neurologic)

Numbness, tingling, or burning sensation in hands and feet due to nerve damage from abnormal protein deposition.

Frequency: 2-8% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Liver function assessment

Comprehensive liver function tests and hepatic imaging to evaluate for liver disease causing beta-globulin abnormalities. Regular monitoring helps identify progression and guide management decisions.

monitoring
3

Kidney function evaluation

Assessment of renal function including GFR and proteinuria evaluation to rule out renal causes of beta-globulin abnormalities. This helps differentiate between hepatic and renal etiologies.

monitoring

Additional treatment options

Protein-balanced nutrition

Implementation of appropriate protein intake balanced to individual nutritional needs while supporting hepatic and renal function. Protein requirements vary based on the underlying cause of abnormal globulin levels.

dietary

Hepatoprotective supportive therapy

Use of evidence-based supportive supplements such as milk thistle or other hepatoprotective agents under medical supervision. These should complement rather than replace conventional medical management.

complementary

Immunoglobulin assessment and management

Evaluation of immunoglobulin levels and potential need for immunoglobulin replacement therapy if deficiency is identified. This addresses immune function abnormalities that may correlate with beta-globulin levels.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Beta Globulin Concentration C4476797?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Taher AT, Musallam KM, Cappellini MD. Guidelines for the Management of Non-Transfusion-Dependent Thalassemia. Thalassaemia International Federation; 2023.

guideline2023View source →
2

National Institutes of Health. Evidence-Based Management of Beta-Thalassemia. NIH Clinical Practice Guidelines. 2022.

guideline2022View source →
3

Cao A, Galanello R. Beta-thalassemia. Genetics in Medicine. 2010;12(2):61-76. doi:10.1097/GIM.0b013e3181cd68ed

review2010View source →
4

American Society of Hematology. Clinical Practice Guidelines for Beta-Thalassemia. ASH Guidelines. 2020.

position_statement2020View source →
5

International Thalassemia Federation. Guidelines for the Clinical Management of Thalassemia. 2nd Edition. 2014; Updated 2021.

consensus2021View source →
6

Rachmilewitz EA, Giardina PJ. How to treat beta-thalassemia. Blood. 2011;118(13):3479-3488. doi:10.1182/blood-2010-08-302497

review2011View source →
7

Hoffbrand AV, Higgs DR, Keeling BM, Mehta AB. Postgraduate Haematology. 7th Edition. Wiley-Blackwell; 2016.

textbook2016View source →
8

Karimi M, Cohan N, De Sanctis V, et al. Guidelines for diagnosis and management of Beta-thalassemia intermedia. Mediterranean Journal of Hematology and Infectious Diseases. 2014;6(1):e2014058.

meta_analysis2014View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Beta Globulin Concentration C4476797. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy